Ads
related to: abbvie stock price
Search results
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
Reuters via Yahoo Finance Canada· 12 hours agoShares of Waltham, Massachusetts-based Morphic surged nearly 75% to $55.62 in morning trading on...
Eli Lilly to buy bowel disease drug developer Morphic for US$3.2-billion
The Globe and Mail· 10 hours agoShares of drug developer Morphic surged 76 per cent to $56.15 premarket on Lilly’s offer of $57 per...